Tejal Somvanshi
Actress Busy Philipps shared her experience with a brain tumor discovery and two surgeries, offering a detailed account of how imaging found the problem and how she recovered. Her story illustrates how medical scanning can reveal unexpected conditions.
Philipps underwent an elective full-body MRI scan through a service called Prenuvo. During that routine screening, doctors found a 2.6-centimeter mass in her brain. She did not have symptoms that made her seek medical attention—the scan discovered the problem during a preventative screening. After diagnostic confirmation, she underwent brain surgery on March 2 to remove the mass.
The surgery identified the tumor as a grade 2 oligodendroglioma. Oligodendroglioma means the tumor came from cells called oligodendrocytes that support nerve tissue in the brain. Grade 2 oligodendroglioma is classified as a low-grade tumor that generally grows slowly. Treatment decisions depend on multiple factors including the extent of surgical removal, molecular characteristics, age, and location of the tumor.
The surgery was extensive, taking five hours. Surgical teams removed the mass. Philipps reported that the tumor was completely removed and that she does not require chemotherapy or radiation therapy after surgery. Instead, she planned regular monitoring with scans every three months for two years.
One month into recovery, in April, Philipps developed a staphylococcus bacterial infection at the surgical incision site. This complication required a second surgery to clean away the infected tissue. She received antibiotic treatment to address the infection. This secondary surgery and infection extended her recovery timeline significantly.
Throughout her treatment, Philipps received support from family and colleagues. Actress Michelle Williams acknowledged Philipps during an awards presentation, providing public recognition of her difficult health challenge.
Important context: Philipps’ experience should not be interpreted as a recommendation for all people to obtain full-body MRI scans. Her case is her own. Medical and radiology organizations have noted concerns about insufficient clinical evidence supporting total-body MRI screening in asymptomatic people and the possibility that screening can lead to incidental findings requiring unnecessary follow-up testing. Whether asymptomatic screening is appropriate is an individual decision based on medical history, risk factors, age, and other considerations—not something one person’s positive experience determines for everyone.
What Philipps’ story does illustrate is how modern imaging can detect problems before symptoms appear and how sophisticated brain surgery and post-operative care have become. Her recovery appears to be progressing without need for chemotherapy or radiation, which represents a favorable outcome for this particular tumor type and grade.
Her public discussion helps reduce stigma around neurological conditions and brain surgery. Many people experience brain tumors, but fewer discuss them publicly. Philipps’ openness provides perspective on diagnosis, treatment options, and recovery.
